Dietram Scheufele, professor of life sciences communication at UW-Madison and Morgridge Institute for Research affiliate, will serve on a national panel examining the implications of human genome editing.
Pilar Ossorio, the Morgridge Institute for Research bioethicist in residence, will serve on an international committee convened by the National Academies of Science (NAS) to address the ethically challenging frontiers of human gene editing technology.
The human genome contains our most personal and sensitive information—the complete compendium of our inherited traits. Even the smallest samples of human tissue and accompanying health histories provide vast troves of data to the biomedical community, which in turn has a legal and ethical obligation to safeguard its usage.
As the cost of whole genome sequencing (WGS) approaches $1,000, the possibility of using it to help diagnose patients becomes economically feasible. But is it the right tool for doctors?
A new service will provide the University of Wisconsin-Madison research community with another checkpoint on ethical challenges that arise across the research spectrum, from study design to the implications of results.